IDStewardship

JUNE 19, 2025

AI-Generated Summary This article by infectious diseases pharmacist Aneeka Chavda outlines five key considerations for pharmacists in the treatment of Mycobacterium tuberculosis (TB), particularly drug-sensitive cases. The piece advocates for therapeutic drug monitoring (TDM) in specific high-risk groups to personalize treatment.

HIV Treatment and Prevention Agents 130

HIV Treatment and Prevention Agents Adverse Reactions Dosage Labelling 130

ISPE

JULY 6, 2023

1 , 4 A Retrospective Journey In 2015, Vertex’s Orkambi was the first approved drug produced under a CM process for the treatment of cystic fibrosis. An average of two approved drugs via CM per year since 2015 shows that progress has been slow but steady and that interest in CM and its potential has been sustained.

HIV Treatment and Prevention Agents 52

HIV Treatment and Prevention Agents Dosage Pharmaceutical Companies Pharmaceutical Companies 52

The Thyroid Pharmacist

JULY 20, 2023

And as we’ve seen, even with supplementation, you need to address your root causes to prevent iron supply and demand challenges. In 2015, some 80 percent of my clients who took the gut tests that I recommended, tested positive for at least one gut infection!) Too much iron/ferritin can be a problem. However, when they added 1.5

Health and Personal Care Stores 98

Health and Personal Care Stores HIV Treatment and Prevention Agents Insurance Immunization 98

The Thyroid Pharmacist

JANUARY 20, 2023

Nikolai Lazarev defined adaptogens as “an agent that raises the body’s ability to resist stress by countering undesired stressors, whether physical, chemical, emotional, or biological.” A 2015 study published in Endokrynologia Polska found the Epstein-Barr virus in the thyroid cells of 80 percent of people with Hashimoto’s and 62.5

HIV Treatment and Prevention Agents 98

HIV Treatment and Prevention Agents Immunization Compounding Documentation 98